HIPO Hippo (HIPO) Insider Trading, Ownership & Congress Trades
Insurance · Fire, marine & casualty insurance · CIK 0001828105
Form 144 · 5
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
81
13F, latest reported quarter
What the filings say about HIPO
Insiders, 180 days
-$1.1M net sold
3 sellers · 30% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$570.9K
5 notices
Hippo insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Hippo Holdings Inc. insiders sold a net $1.1M of stock across 93 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Aug 17, 2026.
- The trade is 1.9% of the 60,655 shares held after it.
- 1 other insider sold within 30 days.
- 81 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO Spinnaker Ostergaard Torben sold about $41.0K of HIPO under a 10b5-1 plan on Oct 15, 2026; 1 other insider sold within 30 days and 81 funds added in the latest 13F quarter.Context
- 18 earlier Form 4 trades (code P or S) here by this insider (2 buys, 16 sales), the last on Sep 9, 2026.
- -31.4% median (-31.4% mean) 90-day return after 2 previous buys.
- The trade is 0.9% of the 562,132 shares held after it.
- 1 other insider sold within 30 days.
- 81 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer McCathron Richard sold about $170.9K of HIPO under a 10b5-1 plan on Oct 9, 2026; 1 other insider sold within 30 days and 81 funds added in the latest 13F quarter.Context
- 17 earlier Form 4 trades (code P or S) here by this insider (2 buys, 15 sales), the last on Aug 10, 2026.
- -31.4% median (-31.4% mean) 90-day return after 2 previous buys.
- The trade is 0.9% of the 567,132 shares held after it.
- 1 other insider sold within 30 days.
- 81 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer McCathron Richard sold about $161.2K of HIPO under a 10b5-1 plan on Sep 9, 2026; 1 other insider sold within 30 days and 81 funds added in the latest 13F quarter.Context
- 14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on May 15, 2026.
- The trade is 1.9% of the 61,824 shares held after it.
- 2 other insiders sold within 30 days.
- 81 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO Spinnaker Ostergaard Torben sold about $38.6K of HIPO on Aug 17, 2026; 2 other insiders sold within 30 days and 81 funds added in the latest 13F quarter.Context
- 16 earlier Form 4 trades (code P or S) here by this insider (2 buys, 14 sales), the last on Jul 9, 2026.
- -31.4% median (-31.4% mean) 90-day return after 2 previous buys.
- The trade is 0.9% of the 580,433 shares held after it.
- 2 other insiders sold within 30 days.
- 81 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer McCathron Richard sold about $160.0K of HIPO on Aug 10, 2026; 2 other insiders sold within 30 days and 81 funds added in the latest 13F quarter.93 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$1.1M over 180 days
-$571.6K over 90 days
more than 63% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
81 funds bought in last quarter
below 71% of Insurance
Revenue
+25.9% year over year
more than 79% of Insurance
Margin
12.3% net margin
more than 56% of Insurance
Buybacks
$14.5M repurchased, FY to 2025-12-31
below 90% of Insurance
Short interest
4.2% of the float short (float per yahoo 2026-10-26) · 4.3 days to cover · settled 2026-09-30
more than 66% of Insurance
What changed in the last 30 days
Oct 16CEO Spinnaker Ostergaard Torben sold $41.0K under a 10b5-1 plan (Oct 15)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 15Officer TORBEN OSTERGAARD filed to sell $40.2K by Oct 15 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 13Chief Executive Officer McCathron Richard sold $170.9K under a 10b5-1 plan (Oct 9)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 9Officer Richard McCathron filed to sell $170.9K by Oct 9 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Watch HIPO
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+8.7%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns HIPO: institutional holders (13F)
13F holdings, latest reported quarter
1,498,306 sh
$42.3M
1,054,035 sh
$29.8M
901,429 sh
$25.5M
898,021 sh
$25.4M
646,908 sh
$18.3M
Congress trades in HIPO
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
HIPO planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
TORBEN OSTERGAARD
Filed 2026-10-15
$40.2K
Richard McCathron
Filed 2026-10-09
$170.9K
Richard McCathron
Filed 2026-09-09
$161.2K
TORBEN OSTERGAARD
Filed 2026-08-17
$38.6K
Richard McCathron
Filed 2026-08-10
$160.0K
HIPO mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
GATOR CAPITAL LONG/SHORT FUND
$556.7K position · as of 2026-07-31
0.7%
Hood River New Opportunities Fund
$8.3M position · as of 2026-06-30
0.7%
Russell Investments U.S. Small Cap Equity ETF
$262.5K position · as of 2026-06-30
0.3%
Royce Quant Small-Cap Quality Value ETF
$57.5K position · as of 2026-06-30
0.2%
Eventide Small Cap ETF
$45.6K position · as of 2026-07-31
0.1%
iShares Micro-Cap ETF
$1.8M position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Richard McCathron
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$6.0M
$6.2M
$1.9M
+121%
+92%
2024
$2.8M
$6.5M
$1.6M
+97%
+90%
2023
$2.7M
$2.0M
$1.9M
-33%
+33%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.1M sold by insiders over 180 days, 81 funds added last quarter, $570.9K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
HIPO financials
Revenue growth
+25.9%
XBRL, annual
Net margin
12.3%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$507.2M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM HIPO
| FY Dec 2025 | $468.6M |
| FY Dec 2024 | $372.1M |
| FY Dec 2023 | $209.7M |
| FY Dec 2022 | $119.7M |
| FY Dec 2021 | $91.3M |
| Jun 2026 | $144.7M |
| Mar 2026 | $121.5M |
| Dec 2025 | $120.4M |
| Sep 2025 | $120.6M |
| Jun 2025 | $117.3M |
| Mar 2025 | $110.3M |
| Dec 2024 | $101.9M |
| Sep 2024 | $95.5M |
At each fiscal year end
Single quarter
Net margin, TTM
+24.9%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM HIPO
| FY Dec 2025 | +13.4% |
| FY Dec 2024 | -7.7% |
| FY Dec 2023 | -125.4% |
| FY Dec 2022 | -278.5% |
| FY Dec 2021 | -406.7% |
| Jun 2026 | +7.0% |
| Mar 2026 | +5.8% |
| Dec 2025 | +9.1% |
| Sep 2025 | +81.3% |
| Jun 2025 | +1.1% |
| Mar 2025 | -43.2% |
| Dec 2024 | +55.1% |
| Sep 2024 | -8.9% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$71.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM HIPO
| FY Dec 2025 | $9.1M |
| FY Dec 2024 | $47.2M |
| FY Dec 2023 | -$122.0M |
| FY Dec 2022 | -$166.4M |
| FY Dec 2021 | -$125.3M |
| Jun 2026 | $43.0M |
| Mar 2026 | $8.4M |
| Dec 2025 | $3.2M |
| Sep 2025 | $16.8M |
| Jun 2025 | $24.8M |
| Mar 2025 | -$35.7M |
| Dec 2024 | -$6.5M |
| Sep 2024 | $46.8M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity HIPO
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt HIPO
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+31.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity HIPO
| FY Dec 2025 | +15.7% |
| FY Dec 2024 | -7.7% |
| FY Dec 2023 | -54.3% |
| FY Dec 2022 | -46.0% |
| FY Dec 2021 | -112.5% |
| Jun 2026 | +31.6% |
| Mar 2026 | +30.4% |
| Dec 2025 | +15.7% |
| Sep 2025 | +28.8% |
| Jun 2025 | +0.4% |
| Mar 2025 | -12.0% |
| Dec 2024 | -7.7% |
| Sep 2024 | -31.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+6.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets HIPO
| FY Dec 2025 | +3.6% |
| FY Dec 2024 | -1.9% |
| FY Dec 2023 | -17.0% |
| FY Dec 2022 | -20.8% |
| FY Dec 2021 | -28.3% |
| Jun 2026 | +6.3% |
| Mar 2026 | +6.5% |
| Dec 2025 | +3.6% |
| Sep 2025 | +6.3% |
| Jun 2025 | +0.1% |
| Mar 2025 | -2.7% |
| Dec 2024 | -1.9% |
| Sep 2024 | -7.3% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital HIPO
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed HIPO
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
8.23x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing HIPO
| FY Dec 2025 | 13.93x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 13.58x |
| Jun 2026 | 6.05x |
| Mar 2026 | 6.00x |
| Dec 2025 | 13.93x |
| Sep 2025 | 9.75x |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value HIPO
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.0%
TTM free cash flow over market value at close 2026-10-23
FCF yield HIPO
| FY Dec 2025 | +1.2% |
| FY Dec 2024 | +7.2% |
| FY Dec 2023 | -56.0% |
| FY Dec 2022 | -53.1% |
| FY Dec 2021 | -0.3% |
| Jun 2026 | +9.7% |
| Mar 2026 | +7.9% |
| Dec 2025 | +1.2% |
| Sep 2025 | -0.1% |
| Jun 2025 | +4.2% |
| Mar 2025 | -1.0% |
| Dec 2024 | +7.2% |
| Sep 2024 | +1.1% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing HIPO
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $468.6M | $372.1M | $209.7M | $119.7M |
| Net income | $62.6M | -$28.6M | -$263.0M | -$333.4M |
| EPS (diluted) | 2.22 | -1.64 | -11.58 | -14.66 |
| Operating cash flow | $9.2M | $47.5M | -$92.4M | -$161.5M |
| Cash | $218.3M | $197.6M | $142.1M | $194.5M |
| Buybacks | $14.5M | $15.6M | $1.8M | $0 |
SEC XBRL, fiscal years, as known on 2026-10-27
HIPO Stock Sonar score 5/7 axes
Find similar shapesCompareHIPO ranks highest on profitability (83rd percentile) and growth (79th), and lowest on institutional and government (29th), among Insurance peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HIPO filings, in plain words
Are Hippo insiders buying or selling HIPO?
In the 180 days to 2026-10-27, Hippo insiders were net sellers, a net $1.1M across purchases and sales reported on Form 4, by 3 sellers.
Are there planned insider sales of HIPO?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $570.9K of stock; the latest, by TORBEN OSTERGAARD, was filed 2026-10-15.
Read the full summary
In the 180 days to 2026-10-27, Hippo insiders were net sellers of HIPO, a net $1.1M across purchases and sales reported on Form 4 by 3 sellers. 30% of the 10 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $570.9K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
